We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Tag: ADHD
MedXY News
EnglishTag

ADHD

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence Review
Clinical Updatespostpartum mental healthPregnancy

Psychostimulant Continuation and Postpartum Mental Health in Pregnant People With Attention-Deficit/Hyperactivity Disorder: A Clinical Evidence Review

By MedXY|Sep 9, 2026

This review synthesizes current evidence on the impact of continuing psychostimulant treatment during pregnancy on postpartum mental health outcomes among people with ADHD, highlighting key findings and clinical implications from recent lar

Sibling-Controlled Evidence Reassures Safety of Prenatal Acetaminophen Use Regarding Autism and ADHD Risks
newsepidemiologyprenatal exposure

Sibling-Controlled Evidence Reassures Safety of Prenatal Acetaminophen Use Regarding Autism and ADHD Risks

By MedXY|Aug 18, 2026

A large sibling-matched cohort study found no link between prenatal acetaminophen exposure and autism or ADHD, suggesting prior associations were confounded by familial factors and supporting the safety of indicated paracetamol use during p

Earlier ADHD Diagnosis May Mark a Better Educational Trajectory: What a Finnish Registry Study Found
newsADHDeducational outcomes

Earlier ADHD Diagnosis May Mark a Better Educational Trajectory: What a Finnish Registry Study Found

By MedXY|Jun 19, 2026

In a nationwide Finnish cohort, earlier ADHD diagnosis was linked to better school performance, more academic progression, and less dropout than diagnosis closer to age 16, especially before educational track selection.

Mapping ADHD Heterogeneity: A New Frontier in Neurobiological Biotyping through Morphometric Similarity Networks
Clinical UpdatesADHDNeuroimaging

Mapping ADHD Heterogeneity: A New Frontier in Neurobiological Biotyping through Morphometric Similarity Networks

By MedXY|Mar 2, 2026

This review explores a groundbreaking study using normative modeling and morphometric similarity networks to identify three distinct neurobiological biotypes of ADHD, providing a framework for precision psychiatry.

Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife
newsADHDchronic disease

Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife

By MedXY|Feb 12, 2026

A 46-year longitudinal study reveals that childhood ADHD traits significantly predict higher rates of physical health conditions, multimorbidity, and disability by middle age, mediated by modifiable risk factors like smoking, BMI, and psych

Prenatal Maternal Depression as a Critical Developmental Risk Factor: Large-Scale IPD Meta-Analysis of 76,514 Children
newsADHDchild development

Prenatal Maternal Depression as a Critical Developmental Risk Factor: Large-Scale IPD Meta-Analysis of 76,514 Children

By MedXY|Feb 7, 2026

This large-scale individual participant data meta-analysis of 76,514 children reveals that prenatal maternal depression is significantly associated with increased risks of ADHD, ASD, and behavioral symptoms, independent of pre-pregnancy dep

Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes
newsADHDMaternal Mental Health

Deciphering Prenatal Risks: Why Maternal Health, Not Medication, Often Drives Neurodevelopmental Outcomes

By MedXY|Jan 25, 2026

Recent large-scale cohort studies suggest that previously observed links between prenatal exposure to acid-suppressants or antipsychotics and neurodevelopmental disorders are largely due to familial confounding. Conversely, active maternal

Lifespan Management of ADHD: Landmark Umbrella Review Identifies Optimal Interventions and Critical Evidence Gaps
newsADHDEvidence-Based Medicine

Lifespan Management of ADHD: Landmark Umbrella Review Identifies Optimal Interventions and Critical Evidence Gaps

By MedXY|Dec 30, 2025

A comprehensive BMJ umbrella review synthesizes evidence for ADHD interventions across the lifespan, confirming the efficacy of stimulants and non-stimulants in the short term while revealing a critical lack of high-certainty long-term data

Methylphenidate for ADHD in Children and Adolescents: Modest Symptom Gains but Uncertain Net Benefit
newsADHDMethylphenidate

Methylphenidate for ADHD in Children and Adolescents: Modest Symptom Gains but Uncertain Net Benefit

By MedXY|Dec 16, 2025

Updated Cochrane analysis (212 RCTs, 16,302 participants) finds methylphenidate may reduce teacher-rated ADHD symptoms and improve general behaviour but increases non‑serious adverse events; overall evidence certainty is very low.

Maternal Paracetamol in Pregnancy and Child Neurodevelopment: Current Evidence Does Not Establish a Clear Causal Link
newsADHDautism

Maternal Paracetamol in Pregnancy and Child Neurodevelopment: Current Evidence Does Not Establish a Clear Causal Link

By MedXY|Nov 22, 2025

An umbrella review of systematic reviews finds low to critically low confidence in studies linking prenatal paracetamol exposure to autism or ADHD; sibling-controlled analyses largely attenuate associations. Clinical guidance: use lowest ef

Telehealth Prescribing of ADHD Stimulants: Assessing Risks for Subsequent Substance Use Disorders
newsADHDStimulant Use Disorder

Telehealth Prescribing of ADHD Stimulants: Assessing Risks for Subsequent Substance Use Disorders

By MedXY|Oct 30, 2025

This study evaluates whether initiating ADHD stimulant prescriptions via telehealth affects later risks of stimulant or other substance use disorders, finding no SUD risk increase but a potential rise in stimulant use disorder risk.

Early Diagnosis and Treatment Patterns of ADHD in Preschool Children: Insights from a National Electronic Health Record Study
newsADHDhealthcare disparities

Early Diagnosis and Treatment Patterns of ADHD in Preschool Children: Insights from a National Electronic Health Record Study

By MedXY|Oct 27, 2025

This study analyzes the diagnosis and medication initiation of ADHD among children aged 3-5 across multiple US health systems, highlighting sociodemographic disparities and clinical practices.

Rising Trends in Stimulant Use Disorder Diagnoses Among Adolescent and Young Adult Medicaid Enrollees: Implications for Clinical Practice
newsADHDadolescents

Rising Trends in Stimulant Use Disorder Diagnoses Among Adolescent and Young Adult Medicaid Enrollees: Implications for Clinical Practice

By MedXY|Oct 15, 2025

Stimulant use disorder diagnoses in young adult Medicaid enrollees have markedly increased from 2001 to 2020, especially for noncocaine psychostimulants, highlighting an urgent need for targeted interventions and evidence-based treatments a

Unraveling ADHD: Gut Microbial Signatures and the Role of SCFA Deficiency in Symptom Pathogenesis
NeurologyADHDgut microbiota

Unraveling ADHD: Gut Microbial Signatures and the Role of SCFA Deficiency in Symptom Pathogenesis

By MedXY|Oct 6, 2025

Recent research reveals distinct gut microbial and metabolic profiles linked to ADHD symptoms, highlighting short-chain fatty acid deficiency as a key mechanism driving hyperactivity and inattention.

ADHD Drugmakers Double Marketing Spending to Clinicians: Implications for Prescribing and Patient Care
Medical NewsADHDprescribing patterns

ADHD Drugmakers Double Marketing Spending to Clinicians: Implications for Prescribing and Patient Care

By MedXY|Oct 6, 2025

Pharmaceutical companies have significantly increased marketing payments to clinicians for ADHD medications, particularly targeting advanced practice clinicians. The impact of this trend on prescribing patterns and clinical benefits remains

Micronutrient Supplementation Modulates Gut Microbiome in Children with ADHD: Insights from the MADDY Study
Family Medicine & NutritionADHDgut microbiome

Micronutrient Supplementation Modulates Gut Microbiome in Children with ADHD: Insights from the MADDY Study

By MedXY|Oct 5, 2025

The MADDY study reveals that micronutrient supplementation in children with ADHD alters gut microbial diversity and composition, notably increasing beneficial butyrate-producing bacteria, potentially underpinning improved behavioral outcome

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation
AIADHDexercise rehabilitation

Harnessing Mobile Health to Improve ADHD Symptoms and Executive Functions in Children: A Randomized Controlled Trial of Tailored Exercise Rehabilitation

By MedXY|Oct 4, 2025

A tailored, app-supported exercise program delivered via mobile health significantly improves core ADHD symptoms and executive functions in children, demonstrating comparable effectiveness to traditional face-to-face exercise guidance.

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD
Allergy & ImmunologyAcceptance and Commitment TherapyADHD

Empowering Parents: Acceptance and Commitment Therapy for Children With Asthma and ADHD

By MedXY|Oct 1, 2025

A randomized clinical trial demonstrates that an Acceptance and Commitment Therapy-based parenting program reduces health care use, improves asthma control, and alleviates ADHD symptoms in children with both conditions.

Aluminum-Adjuvanted Vaccines in Early Childhood and Risk of Chronic Autoimmune, Allergic, and Neurodevelopmental Disorders: Insights from a Danish Nationwide Cohort Study
Clinical UpdatesADHDautism spectrum disorder

Aluminum-Adjuvanted Vaccines in Early Childhood and Risk of Chronic Autoimmune, Allergic, and Neurodevelopmental Disorders: Insights from a Danish Nationwide Cohort Study

By MedXY|Sep 30, 2025

A comprehensive Danish cohort study finds no evidence linking early childhood aluminum-adsorbed vaccines to increased risks of autoimmune, allergic, or neurodevelopmental disorders, supporting vaccine safety.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story